Semin Thromb Hemost 2024; 50(02): 271-274
DOI: 10.1055/s-0043-1770051
Review Article

Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review

Giuseppe Lippi
1   Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy
,
Emmanuel J. Favaloro
2   Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW Australia
3   School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia
4   Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia
› Institutsangaben
Preview

Abstract

Long-coronavirus disease 2019 (COVID-19) represents a heterogeneous clinical syndrome characterized by a pathologic continuum of signs, symptoms, and also laboratory/radiologic abnormalities that may persist for a long time after recovering from an acute severe acute respiratory syndrome-coronavirus disease 2 infection. Among the various components of this postviral condition, the risk of venous thromboembolism in patients hospitalized for COVID-19 remains considerably higher after discharge, especially in older individuals, in men, in patients with longer hospital stays and more aggressive treatment (e.g., mechanical ventilation and/or intensive care), when thromboprophylaxis is not used, and in those with a persistent prothrombotic state. Patients who have these predisposing factors should be monitored more closely to intercept any thrombosis that may occur in a post-COVID time-related manner but may also benefit from extended thromboprophylaxis and/or antiplatelet therapy.



Publikationsverlauf

Artikel online veröffentlicht:
16. Juni 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA